Cargando…

Synthesis and Neuroprotective Action of Xyloketal Derivatives in Parkinson’s Disease Models

Parkinson’s disease (PD) is the second most common neurodegenerative disease affecting people over age 55. Oxidative stress actively participates in the dopaminergic (DA) neuron degeneration of PD. Xyloketals are a series of natural compounds from marine mangrove fungus strain No. 2508 that have bee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shichang, Shen, Cunzhou, Guo, Wenyuan, Zhang, Xuefei, Liu, Shixin, Liang, Fengyin, Xu, Zhongliang, Pei, Zhong, Song, Huacan, Qiu, Liqin, Lin, Yongcheng, Pang, Jiyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877910/ https://www.ncbi.nlm.nih.gov/pubmed/24351912 http://dx.doi.org/10.3390/md11125159

Ejemplares similares

Design and Synthesis of Novel Xyloketal Derivatives and Their Protective Activities against H(2)O(2)-Induced HUVEC Injury
por: Liu, Shixin, et al.
Publicado: (2015)

Xyloketal-derived small molecules show protective effect by decreasing mutant Huntingtin protein aggregates in Caenorhabditis elegans model of Huntington’s disease
por: Zeng, Yixuan, et al.
Publicado: (2016)

Xyloketal derivative C53N protects against mild traumatic brain injury in mice
por: Liang, Fengyin, et al.
Publicado: (2018)

Marine Compound Xyloketal B as a Potential Drug Development Target for Neuroprotection
por: Gong, Haifan, et al.
Publicado: (2018)

Xyloketal B Attenuates Fatty Acid-Induced Lipid Accumulation via the SREBP-1c Pathway in NAFLD Models
por: Zhang, Youying, et al.
Publicado: (2017)

Marine Compound Xyloketal B Reduces Neonatal Hypoxic-Ischemic Brain Injury
por: Xiao, Ai-Jiao, et al.
Publicado: (2014)

Xyloketal B Exhibits Its Antioxidant Activity through Induction of HO-1 in Vascular Endothelial Cells and Zebrafish
por: Li, Zhen-Xing, et al.
Publicado: (2013)

Xyloketal B Attenuates Atherosclerotic Plaque Formation and Endothelial Dysfunction in Apolipoprotein E Deficient Mice
por: Zhao, Li-Yan, et al.
Publicado: (2015)

Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal study
por: Su, Junhui, et al.
Publicado: (2014)

Neuroprotective actions of a fatty acid nitroalkene in Parkinson’s disease
por: Di Maio, Roberto, et al.
Publicado: (2023)

Xyloketal B Suppresses Glioblastoma Cell Proliferation and Migration in Vitro through Inhibiting TRPM7-Regulated PI3K/Akt and MEK/ERK Signaling Pathways
por: Chen, Wen-Liang, et al.
Publicado: (2015)

Tremor and clinical fluctuation are related to sleep disorders in Chinese patients with Parkinson’s disease
por: Zhou, Hongyan, et al.
Publicado: (2014)

Addressing the Neuroprotective Actions of Coffee in Parkinson’s Disease: An Emerging Nutrigenomic Analysis
por: Lee, Lai Kuan, et al.
Publicado: (2022)

High expression levels of the D686N Parkinson's disease mutation in VPS35 induces α-synuclein-dependent toxicity in yeast
por: Huang, Yi, et al.
Publicado: (2017)

Enriched Brain Omega-3 Polyunsaturated Fatty Acids Confer Neuroprotection against Microinfarction
por: Luo, Chuanming, et al.
Publicado: (2018)

Neuroprotective Actions of Neurosteroids
por: Borowicz, Kinga K., et al.
Publicado: (2011)

Synthesis and Neuroprotective Action of Optically Pure Neoechinulin A and Its Analogs
por: Aoki, Toshiaki, et al.
Publicado: (2010)

Potential protective effects of autophagy activated in MPP+ treated astrocytes
por: Shen, Cunzhou, et al.
Publicado: (2016)

Studies on Synthesis and Structure-Activity Relationship (SAR) of Derivatives of a New Natural Product from Marine Fungi as Inhibitors of Influenza Virus Neuraminidase
por: Li, Jing, et al.
Publicado: (2011)

Synthesis of Melatonin Derivatives and the Neuroprotective Effects on Parkinson’s Disease Models of Caenorhabditis elegans
por: He, Li, et al.
Publicado: (2022)

Neurodegeneration and neuroprotection in Parkinson's disease /
Publicado: (1996)

Neuroprotective Actions of Dietary Choline
por: Blusztajn, Jan Krzysztof, et al.
Publicado: (2017)

Chaperone Sigma1R mediates the neuroprotective action of afobazole in the 6-OHDA model of Parkinson’s disease
por: Voronin, Mikhail V., et al.
Publicado: (2019)

The Promise of Neuroprotective Agents in Parkinson’s Disease
por: Seidl, Stacey E., et al.
Publicado: (2011)

Neuroprotection in Parkinson’s disease: facts and hopes
por: Salamon, András, et al.
Publicado: (2019)

Sulfhydration mediates neuroprotective actions of parkin
por: Vandiver, M. Scott, et al.
Publicado: (2013)

Medical Management of Parkinson’s Disease: Focus on Neuroprotection
por: Boll, Marie-Catherine, et al.
Publicado: (2011)

Neuroprotection by Nrf2 in Parkinson’s disease model
Publicado: (2011)

Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection
por: Mounsey, Ross B., et al.
Publicado: (2010)

Erratum: The promise of neuroprotective agents in Parkinson's disease
por: Seidl, Stacey E., et al.
Publicado: (2013)

Neuroprotective Function of DJ-1 in Parkinson's Disease
por: Ariga, Hiroyoshi, et al.
Publicado: (2013)

On the role of endogenous neurotoxins and neuroprotection in Parkinson's disease
por: Segura-Aguilar, Juan
Publicado: (2017)

Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson’s Disease
por: Ferreira, Carla, et al.
Publicado: (2020)

Editorial: Neuroprotection and Disease Modification in Parkinson’s Disease
por: Otero-Losada, Matilde, et al.
Publicado: (2021)

Design and Synthesis of Brain Penetrant Glycopeptide Analogues of PACAP With Neuroprotective Potential for Traumatic Brain Injury and Parkinsonism
por: Apostol, Christopher R., et al.
Publicado: (2022)

Synthesis and Evaluation of Neuroprotective Selenoflavanones
por: Choi, Yong-Sung, et al.
Publicado: (2015)

Neuroprotective Actions of Ghrelin and Growth Hormone Secretagogues
por: Frago, Laura M., et al.
Publicado: (2011)

Neuroprotective Actions of Methylene Blue and Its Derivatives
por: Poteet, Ethan, et al.
Publicado: (2012)

A new face of orexins action - neuroprotection
por: Zawilska, Jolanta
Publicado: (2015)

Antioxidant and neuroprotective actions of resveratrol in cerebrovascular diseases
por: Wang, Qing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eqpa8rpt786t5kb49cqougg15e